DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Gómez-Almaguer D, Tarín-Arzaga L, Moreno-Jaime B , et al.
High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.
Eur J Haematol 2013;
90 (6) 494-500
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.